Comment on FR Doc # 2026-09877, NRC-2025-1205-0001, from Society of Nuclear Medicine and Molecular Imaging
Society of Nuclear Medicine and Molecular ImagingSupportAdvocacy
Summary: The Society of Nuclear Medicine and Molecular Imaging (SNMMI) supports the NRC's proposed rulemaking to modernize byproduct material regulations, noting it will reduce regulatory burdens and increase patient access to radiopharmaceuticals. The organization specifically advocates for risk-informed radionuclide activity values, the creation of standard general licenses (SGLs), and expanded distribution pathways for microsources.
See attached file(s)